The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

Press Releases

RAPS releases updated Regulatory Competency Framework

Posted 30 November 2021 | By Zachary Brousseau 

RAPS today announced the release of its updated Regulatory Competency Framework, describing the essential elements of what is required of regulatory professionals at four key career and profes...

RAPS Convergence 2021 brings regulatory community together virtually to hear from regulators, learn from each other and celebrate the profession

Posted 15 September 2021 | By Zachary Brousseau 

RAPS today wrapped up its annual RAPS Convergence, the world’s largest conference dedicated to healthcare product regulation and regulatory issues. The event drew more than 1,500 participants ...

Global regulatory workforce nearly 100K, says new report from RAPS, Elemed

Posted 15 September 2021 | By Zachary Brousseau 

Nearly 100,000 professionals around the world currently work in the field of regulatory affairs for healthcare products, such as pharmaceuticals, medical devices, and biotechnology products, i...

RAPS honors 7 distinguished individuals and an advocacy group for contributions to the regulatory profession and patient health

Posted 09 September 2021 | By Zachary Brousseau 

RAPS has recognized seven distinguished professionals and one patient advocacy organization with awards for their work to support the regulatory profession and advance public health. RAPS’ Fou...

Chisholm, Falcone, Soo and Steffen named RAPS Fellows

Posted 02 September 2021 | By Zachary Brousseau 

RAPS today announced that Orin Chisholm, Robert Falcone, Chin-Wei Soo and Beat Steffen have been selected to join the venerated ranks of RAPS Fellows.

RAPS in the News

FDA delays collecting drugmaker data required by CARES Act | Becker's ASC Review

Posted 26 August 2020 | By Maia Anderson

...new data required from drugmakers under the Coronavirus Aid, Relief, and Economic Security Act next month, though the measure is set to take effect Sept. 23, Regulatory Focus reported.

V is for vaccine | The Star

Posted 22 August 2020

According to Regulatory Affairs Professional Society (RAPS), it will take a fast-tracked vaccine development anywhere between 12 and 18 months to be marketed commercially...

Pfizer Eyes Vaccine Race Finish Line | Investopedia

Posted 21 August 2020 | By Deborah D'Souza

Source: Regulatory Affairs Professionals Society...

FDA publicizes 20 device shortages, 1 discontinuation | Becker's ASC Review

Posted 17 August 2020 | By Angie Stewart

...required to notify the FDA of events that could disrupt the supply of a device during the public health emergency, according to the Regulatory Affairs Professionals Society.

The European Commission has reached a first agreement with AstraZeneca to purchase a potential vaccine against covid-19. | Delano

Posted 15 August 2020 | By Jess Bauldry

...19 vaccines are being developed around the world, according to the Regulatory Affairs Professional Society. Currently ...

     
  •  
  • 1
  •  
  • 2
  •  
  •